rs72554028
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_004387.4(NKX2-5):c.543G>C(p.Gln181His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q181P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_004387.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NKX2-5 | NM_004387.4 | c.543G>C | p.Gln181His | missense_variant | 2/2 | ENST00000329198.5 | NP_004378.1 | |
NKX2-5 | NM_001166176.2 | c.*342G>C | 3_prime_UTR_variant | 2/2 | NP_001159648.1 | |||
NKX2-5 | NM_001166175.2 | c.*496G>C | 3_prime_UTR_variant | 2/2 | NP_001159647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NKX2-5 | ENST00000329198.5 | c.543G>C | p.Gln181His | missense_variant | 2/2 | 1 | NM_004387.4 | ENSP00000327758.4 | ||
NKX2-5 | ENST00000424406 | c.*496G>C | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000395378.2 | ||||
NKX2-5 | ENST00000521848 | c.*342G>C | 3_prime_UTR_variant | 2/2 | 2 | ENSP00000427906.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Atrial septal defect 7 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 15, 2016 | Variant summary: The NKX2-5 c.543G>C (p.Gln181His) variant involves the alteration of a conserved nucleotide and results in a replacement of a medium size and polar Glutamine (Q) with a medium size and polar Histidine (H). 4/5 in silico tools predict a damaging outcome for this substitution. This variant is absent in 90576 control chromosomes while it was reported in many atrioventricular conduction disease (AVCD) patients indicating pathogenicity. Moreover, in an AVCD family the variant was shown to co-segregate with the disease further supporting a deleterious outcome. In addition, a functional study demonstrated to variant to result in significantly decreased transcriptional activity at the atrial natriuretic factor promoter. Taken together, this variant is classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at